GO:0032735 positive regulation of interleukin-12 production: Immune Regulation Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0032735 describes any process that activates or increases the frequency, rate, or extent of interleukin-12 (IL-12) production.
• IL-12 is a heterodimeric cytokine critical for driving T helper 1 (Th1) responses and interferon-gamma (IFN-gamma) production.
• Positive regulation of IL-12 production involves coordinated signaling through pattern recognition receptors, cytokines, and transcription factors.
• Dysregulated IL-12 production is implicated in autoimmune diseases, chronic inflammation, and cancer immunosurveillance.
• Key genes controlling this process include IL12A, IL12B, TLRs, MYD88, NFKB1, and IRF family members.
• CRISPR-based models (knockout, knock-in, overexpression) enable precise dissection of IL-12 regulatory networks.
Description
Interleukin-12 (IL-12) is a pivotal cytokine that bridges innate and adaptive immunity by promoting Th1 differentiation and IFN-gamma secretion. The Gene Ontology term GO:0032735, positive regulation of interleukin-12 production, encompasses all molecular events that enhance the synthesis, secretion, or bioavailability of this heterodimeric cytokine. Understanding this process is essential for immunologists studying host defense, autoimmunity, and cancer immunotherapy. The regulation of IL-12 production is tightly controlled at transcriptional and post-transcriptional levels, involving pattern recognition receptors, cytokines, and intracellular signaling cascades. Dysregulation of this pathway contributes to a spectrum of diseases, from inflammatory bowel disease to psoriasis and malignancies. Recent advances in CRISPR gene editing have enabled researchers to systematically interrogate the genes that positively regulate IL-12 production, providing new insights into immune regulation and therapeutic targets.
positive regulation of interleukin-12 production At A Glance
| GO ID | GO:0032735 |
|---|---|
| GO term | positive regulation of interleukin-12 production |
| Ontology | biological_process |
| Synonym | activation of interleukin-12 production; positive regulation of IL-12 production; stimulation of interleukin-12 production; upregulation of interleukin-12 production |
| Major function | Enhances the production of IL-12, a cytokine critical for Th1 immune responses and IFN-gamma induction. |
| Key regulators | TLRs, MYD88, NF-kB, IRF1, IRF8, and cytokines such as IFN-gamma and GM-CSF. |
| Cellular sources | Dendritic cells, macrophages, monocytes, and B cells. |
| Related diseases | Autoimmunity, chronic inflammation, cancer, and infectious diseases. |
What Is GO:0032735?
GO:0032735 is a biological process term defined as any process that activates or increases the frequency, rate, or extent of interleukin-12 production. This includes transcriptional activation of IL12A and IL12B genes, enhanced assembly and secretion of the IL-12 p70 heterodimer, and stabilization of IL-12 mRNA or protein. The term covers positive regulation by diverse stimuli such as microbial products, cytokines, and costimulatory molecules.
Why Is positive regulation of interleukin-12 production Important in Cell Biology?
Positive regulation of IL-12 production is central to the initiation and amplification of cell-mediated immunity. IL-12 drives the differentiation of naive CD4+ T cells into Th1 cells, which are essential for combating intracellular pathogens and tumor cells. Conversely, excessive or inappropriate IL-12 production can lead to tissue damage and autoimmune pathology. Therefore, understanding the mechanisms that positively regulate IL-12 production is crucial for developing therapies that either boost immunity against cancer and infections or dampen harmful inflammation in autoimmune diseases.
• IL-12 is a key cytokine for Th1 polarization and IFN-gamma production.
• Positive regulation of IL-12 is essential for host defense against intracellular pathogens.
• IL-12 enhances NK cell cytotoxicity and proliferation.
• Dysregulated IL-12 production is associated with autoimmune diseases such as psoriasis and inflammatory bowel disease.
• IL-12 has been used in cancer immunotherapy due to its ability to stimulate antitumor immunity.
• Glucocorticoids differentially regulate IL-10 and IL-12, impacting inflammation resolution.
• IL-12 and IL-18 synergize to regulate ITAM-positive receptors in NK cells.
• IL-15-stimulated lamina propria lymphocytes show massive IL-12-induced IFN-gamma production.
• Bovine IL-12 modulates IFN-gamma production, relevant for veterinary immunology.
• A SNP in SH2B3/LNK affects hypertension and renal damage, highlighting IL-12 pathway crosstalk.
What Happens During positive regulation of interleukin-12 production?
Recognition of Microbial Stimuli
In simple terms: Immune cells detect bacteria or viruses through pattern recognition receptors, which triggers a signal to make more IL-12.
Positive regulation of IL-12 production is initiated when pattern recognition receptors (PRRs) such as Toll-like receptors (TLRs) recognize pathogen-associated molecular patterns (PAMPs). This recognition activates intracellular signaling cascades, including the MyD88-dependent pathway, leading to the activation of transcription factors like NF-kB and IRFs. These transcription factors then bind to the promoters of IL12A and IL12B genes, initiating their transcription.
Transcriptional Activation of IL12A and IL12B
In simple terms: Specific transcription factors turn on the two genes that make the two parts of the IL-12 protein.
The IL-12 p70 heterodimer consists of p35 (encoded by IL12A) and p40 (encoded by IL12B) subunits. Positive regulation involves coordinated transcriptional activation of both genes. Key transcription factors include NF-kB, IRF1, IRF8, and PU.1, which bind to regulatory elements in the IL12A and IL12B promoters. Cytokines such as IFN-gamma and GM-CSF can also enhance transcription through STAT and IRF pathways.
Post-transcriptional and Secretory Regulation
In simple terms: After the genes are turned on, the cell controls how much protein is made and released.
Beyond transcription, positive regulation of IL-12 production involves mRNA stabilization, efficient translation, and proper assembly and secretion of the p70 heterodimer. The p40 subunit can also form homodimers or pair with p19 to form IL-23, so regulation of p35 availability is critical for IL-12 specificity. Secretion is mediated by the classical endoplasmic reticulum-Golgi pathway.
Amplification by Cytokine Feedback
In simple terms: Once IL-12 is produced, it can stimulate other cells to produce more IL-12 or IFN-gamma, creating a positive feedback loop.
IL-12 produced by dendritic cells and macrophages acts on NK and T cells to induce IFN-gamma, which in turn can further enhance IL-12 production by antigen-presenting cells. This positive feedback loop amplifies Th1 responses. Additionally, IL-18 synergizes with IL-12 to enhance IFN-gamma production and regulate ITAM-positive receptors.
Modulation by Glucocorticoids and Other Factors
In simple terms: Stress hormones and other signals can dial down or up IL-12 production.
Glucocorticoids differentially regulate IL-10 and IL-12, typically suppressing IL-12 while enhancing IL-10, thereby shifting the immune response away from Th1. In contrast, IL-15 stimulation of lamina propria lymphocytes leads to massive IL-12-induced IFN-gamma production followed by down-regulation of the IL-12 receptor, illustrating negative feedback. Bovine IL-12 studies show similar modulation of IFN-gamma, highlighting conserved regulatory mechanisms.
Key Genes Involved in GO:0032735 positive regulation of interleukin-12 production
The following genes and proteins are central to the positive regulation of interleukin-12 production, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| IL12A | Encodes the p35 subunit of IL-12 | Essential for IL-12 heterodimer formation; knockout abolishes IL-12 activity. |
| IL12B | Encodes the p40 subunit of IL-12 | Shared with IL-23; critical for IL-12 and IL-23 signaling. |
| TLR4 | Recognizes LPS and triggers MyD88-dependent signaling | Key initiator of IL-12 production in response to Gram-negative bacteria. |
| MYD88 | Adaptor protein for TLR/IL-1R signaling | Central to NF-kB activation and IL-12 transcription. |
| NFKB1 | Transcription factor subunit | Binds IL12B promoter to enhance transcription. |
| IRF1 | Interferon regulatory factor 1 | Enhances IL12A and IL12B transcription in response to IFN-gamma. |
| IRF8 | Interferon regulatory factor 8 | Critical for IL-12 production in dendritic cells. |
| STAT1 | Signal transducer and activator of transcription 1 | Mediates IFN-gamma-induced enhancement of IL-12 production. |
| IFNG | Interferon-gamma | Amplifies IL-12 production via feedback loops. |
| IL18 | Interleukin-18 | Synergizes with IL-12 to induce IFN-gamma. |
| IL15 | Interleukin-15 | Stimulates lymphocytes and modulates IL-12 receptor expression. |
| SH2B3 | LNK adaptor protein | Regulates cytokine signaling; SNP linked to hypertension and renal damage. |
| NR3C1 | Glucocorticoid receptor | Mediates glucocorticoid suppression of IL-12. |
| CD40 | Costimulatory receptor | Enhances IL-12 production in dendritic cells. |
| CD40LG | CD40 ligand | Engages CD40 to boost IL-12 secretion. |
| GM-CSF | Granulocyte-macrophage colony-stimulating factor | Promotes IL-12 production in monocytes/macrophages. |
| IL10 | Interleukin-10 | Negatively regulates IL-12; its balance is critical. |
| PTGS2 | Cyclooxygenase-2 | Prostaglandin E2 suppresses IL-12 production. |
How Is positive regulation of interleukin-12 production Regulated?
Positive regulation of IL-12 production is controlled by a complex network of signaling pathways. TLR engagement activates MyD88 and TRIF, leading to NF-kB, MAPK, and IRF activation. Cytokines such as IFN-gamma and GM-CSF enhance IL-12 production through STAT1 and IRF1/8. Negative regulators include IL-10, TGF-beta, and glucocorticoids, which suppress IL-12 transcription and secretion. Post-transcriptional mechanisms, including mRNA stability and microRNAs, also modulate IL-12 levels. The balance between positive and negative signals determines the magnitude and duration of IL-12 responses, which is critical for effective immunity without excessive inflammation.
positive regulation of interleukin-12 production and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| IL12B | Psoriasis, inflammatory bowel disease | Knockout mice or human cell lines with IL12B deletion. |
| IL12A | Chronic inflammation, cancer | CRISPR knockout in dendritic cells. |
| SH2B3 | Hypertension, renal damage | Point mutation knock-in mice. |
| IL12B | Insulin resistance in acne vulgaris | Overexpression in keratinocytes or adipocytes. |
| IFNG | Mycobacterial infections | Knockout mice or human iPSC-derived macrophages. |
Autoimmune and Inflammatory Diseases
Excessive positive regulation of IL-12 production contributes to the pathogenesis of autoimmune diseases such as psoriasis, inflammatory bowel disease, and rheumatoid arthritis. IL-12 drives Th1 responses that mediate tissue damage. Glucocorticoids suppress IL-12 production, which is one mechanism by which they treat inflammatory conditions. Polymorphisms in IL12B have been associated with susceptibility to these diseases.
Cancer Immunotherapy
IL-12 has potent antitumor activity due to its ability to stimulate cytotoxic T lymphocytes and NK cells and induce IFN-gamma. Positive regulation of IL-12 production is therefore desirable in cancer immunotherapy. Recombinant IL-12 has been tested in clinical trials, though toxicity has limited its use. Understanding the regulatory mechanisms can inform strategies to enhance IL-12 production specifically within the tumor microenvironment.
Infectious Diseases
IL-12 is essential for protective immunity against intracellular pathogens such as Mycobacterium tuberculosis, Leishmania major, and Toxoplasma gondii. Positive regulation of IL-12 production is critical for mounting effective Th1 responses. Deficiencies in IL-12 or its receptor lead to increased susceptibility to these infections. Bovine studies highlight the importance of IL-12 in veterinary infectious diseases.
Metabolic and Other Conditions
A single nucleotide polymorphism in SH2B3/LNK, which regulates cytokine signaling, promotes hypertension and renal damage, suggesting a link between IL-12 pathway and cardiovascular disease. Additionally, IL-12 gene expression has been associated with insulin resistance in acne vulgaris patients. These findings expand the relevance of IL-12 regulation beyond classical immunology.
From positive regulation of interleukin-12 production-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate IL-12 production? | CRISPR knockout of gene X in primary dendritic cells or macrophages. |
| Does a specific SNP in gene Y affect IL-12 levels? | Point mutation knock-in using CRISPR in cell lines. |
| Can a tagged version of IL12B reveal trafficking? | Knock-in of fluorescent or epitope tag at IL12B locus. |
| Does overexpression of gene Z enhance IL-12 production? | Lentiviral overexpression in monocytes. |
| What is the role of gene W in IL-12 regulation in vivo? | Conditional knockout mouse models. |
| Can CRISPR activation (CRISPRa) boost IL-12 production? | dCas9-VP64 activation of IL12A/IL12B promoters. |
How to Study the positive regulation of interleukin-12 production Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptome changes | Identify genes upregulating IL-12 upon stimulation. |
| ELISA | Secreted IL-12 p70 protein | Quantify positive regulation in cell supernatants. |
| Flow cytometry | Intracellular IL-12 and surface markers | Identify IL-12-producing cell subsets. |
| CRISPR knockout screen | Gene requirement for IL-12 production | Discover novel positive regulators. |
| CRISPR activation screen | Gene sufficiency to enhance IL-12 | Identify genes that boost IL-12 when overexpressed. |
| Western blot | Protein levels of p35 and p40 | Validate subunit expression. |
| Luciferase reporter | Promoter activity | Screen transcription factor effects. |
| Proteomics | Protein interactions and modifications | Map IL-12 regulatory complexes. |
Transcriptional Profiling
RNA-seq and qPCR are used to measure IL12A and IL12B mRNA levels following stimulation. This reveals transcriptional changes in response to TLR agonists or cytokines. Single-cell RNA-seq can identify cellular sources of IL-12 in heterogeneous populations.
Protein Quantification
ELISA and Western blot are standard for measuring IL-12 p70 heterodimer secretion and intracellular p35/p40 levels. Flow cytometry can detect IL-12-producing cells using intracellular staining. These methods are critical for validating positive regulation.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that positively or negatively regulate IL-12 production. Cells are stimulated, and IL-12 levels are measured by ELISA or reporter assays, followed by sequencing to identify enriched sgRNAs.
Imaging and Reporter Assays
Luciferase reporters driven by IL12A or IL12B promoters enable high-throughput screening of regulatory factors. Fluorescence microscopy can visualize NF-kB translocation and IL-12 vesicle trafficking.
How CRISPR Can Be Used to Study GO:0032735 positive regulation of interleukin-12 production
Knockout
CRISPR knockout of candidate genes in dendritic cells or macrophages can determine whether they are required for positive regulation of IL-12 production. For example, knocking out MYD88 abolishes TLR-induced IL-12 production. This approach provides causal evidence for gene function.
Point Mutation
Introducing disease-associated SNPs (e.g., in SH2B3) using CRISPR point mutation allows researchers to study their impact on IL-12 regulation and downstream phenotypes like hypertension. This is crucial for understanding genetic variants identified in GWAS.
Knock-in
Knock-in of tags (e.g., FLAG, GFP) at the IL12A or IL12B locus enables tracking of endogenous IL-12 subunits, revealing trafficking and secretion dynamics. Knock-in of reporter genes can also facilitate high-throughput screening.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can test whether increasing a gene's activity enhances IL-12 production. This is useful for identifying rate-limiting factors and potential therapeutic targets.
How EDITGENE Supports positive regulation of interleukin-12 production Research
Researchers studying positive regulation of interleukin-12 production-related genes often need to determine whether a candidate gene is causally involved in enhancing IL-12 levels or is merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal investigations with high precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of interleukin-12 production research.
Frequently Asked Questions About positive regulation of interleukin-12 production
What is GO:0032735?
GO:0032735 is the Gene Ontology term for positive regulation of interleukin-12 production, describing any process that activates or increases the frequency, rate, or extent of IL-12 production.
What genes are involved in positive regulation of interleukin-12 production?
Key genes include IL12A, IL12B, TLR4, MYD88, NFKB1, IRF1, IRF8, and STAT1, among others.
How is IL-12 production positively regulated?
It is positively regulated by pattern recognition receptor signaling, cytokines like IFN-gamma and GM-CSF, and transcription factors such as NF-kB and IRFs.
What diseases are associated with dysregulated IL-12 production?
Autoimmune diseases (psoriasis, IBD), chronic infections, and cancer are associated with altered IL-12 regulation.
Which cells produce IL-12?
Dendritic cells, macrophages, monocytes, and B cells are major producers of IL-12.
What is the role of IL-12 in Th1 responses?
IL-12 drives naive CD4+ T cells to differentiate into Th1 cells, which produce IFN-gamma and mediate cell-mediated immunity.
How can CRISPR be used to study IL-12 regulation?
CRISPR knockout, knock-in, and activation screens can identify and validate genes that positively regulate IL-12 production.
What is the difference between IL-12 and IL-23?
IL-12 and IL-23 share the p40 subunit (IL12B) but have distinct p35 and p19 subunits, respectively, and play different roles in immunity.
Can IL-12 be used in cancer therapy?
Yes, recombinant IL-12 has been tested in clinical trials for its antitumor activity, though toxicity remains a challenge.
What methods measure IL-12 production?
ELISA, flow cytometry, RNA-seq, and reporter assays are commonly used to measure IL-12 production.
Conclusion
Positive regulation of interleukin-12 production (GO:0032735) is a critical biological process that governs the initiation and amplification of Th1 immune responses. Its dysregulation is linked to autoimmune diseases, chronic infections, and cancer. Understanding the molecular mechanisms and key genes involved provides opportunities for therapeutic intervention. CRISPR-based models offer powerful tools to dissect these pathways and identify novel drug targets. EDITGENE's comprehensive services support researchers in this endeavor, from knockout to library screening.
References
- 1. Ma X et al.. 1998. Positive and negative regulation of interleukin-12 gene expression.. Eur Cytokine Netw 9(3 Suppl):54-64 PMID: 9831187
- 2. Alexander MR et al.. 2022. A Single Nucleotide Polymorphism in SH2B3/LNK Promotes Hypertension Development and Renal Damage.. Circ Res 131(9):731-747 PMID: 36169218
- 3. AbdElneam AI et al.. 2023. Effect of interleukin-12 gene expression on insulin resistance in patients with acne vulgaris.. Skin Res Technol 29(11):e13503 PMID: 38009017
- 4. Collins RA et al.. 1999. Bovine interleukin-12 and modulation of IFNgamma production.. Vet Immunol Immunopathol 68(2-4):193-207 PMID: 10438320
- 5. Trinchieri G. 1997. Function and clinical use of interleukin-12.. Curr Opin Hematol 4(1):59-66 PMID: 9050381
- 6. Ortaldo JR et al.. 2006. Regulation of ITAM-positive receptors: role of IL-12 and IL-18.. Blood 107(4):1468-75 PMID: 16249390
- 7. Visser J et al.. 1998. Differential regulation of interleukin-10 (IL-10) and IL-12 by glucocorticoids in vitro.. Blood 91(11):4255-64 PMID: 9596674
- 8. Ebert EC et al.. 2008. Massive interleukin-12-induced interferon-gamma production by interleukin-15-stimulated lamina propria lymphocytes followed by down-regulation of the interleukin-12 receptor.. Immunology 124(4):453-60 PMID: 18540964
